c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
ALPMY
ASTELLAS PHARMA UNSP/ADR
stock
OTC
ADR
EOD
Nov 13, 2026
16.85
USD
+2.029%
(+0.34)
274,487
Pre-market
After-hours
Overview
Company
Exchanges
Shorts
News
News
ALPMY News
1
/
1
Nov 13, 2026
Day breaks
Nov 13, 2026
04:23 PM EST
AstraZeneca gains additional bladder cancer indication for Imfinzi
·
Seeking Alpha
Nov 12, 2026
08:40 AM EST
Astellas, Immuneering Enter Pancreatic Cancer Trial Collaboration
·
RTTNews
Nov 4, 2026
02:57 AM EST
Astellas Pharma (ALPMY) Reports Strong H1 Results, Dividend Sustainability in Focus
·
GuruFocus
02:38 AM EST
Astellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook
·
Seeking Alpha
Nov 3, 2026
06:00 PM EST
Here are the major earnings before the open Wednesday
·
Seeking Alpha
Oct 25, 2026
12:17 PM EDT
AstraZeneca stomach cancer drug doubles survival in late-stage trial
·
Seeking Alpha
Sep 15, 2026
05:58 AM EDT
Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics
·
GlobeNewswire Inc.
stockOTCADR
Seeking AlphastockOTCADR